NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?

Sulayman’s skills include health economic theory and ecoomic modelling with a particular aptitude for econometric analysis and quantitative data. His primary interest is in new technological/biochemical innovations in medicines, their access and their effects on patient populations.
Sulayman’s current research interests include the most current breakthroughs and healthcare system changes such as carer health, gene therapies, mRNA vaccines and more, with a particular interest in new technologies such as AI. His previous experience involved digital health and its effects on the healthcare sector.
An error has occurred, please try again later.An error has occurred, please try again later.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!